A phase Iib openlabel randomized controlled trial to evaluate the efficacy & safety of Ivermectin in reducing viral loads in patients with hematological disorders who are admitted with Covid-19 infection (Ice study)
Implementing Organization
Christian Medical College
Principal Investigator
Dr. B. George Head & Professor Christian Medical College Tamil Nadu
Science & Engineering Research Board - Covid-19 (SERB-COVID)
Start Year
2020
End Year
2021
Duration
12
Sanction Amount
₹ 20.90 L
Status
Completed
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
00
No. of Patents
Filed :00
Grant :00
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.
Christian Medical College
Acces sibility Controls